Abbott Laboratories (ETR:ABL)
107.18
+0.76 (0.71%)
At close: Dec 22, 2025
Abbott Laboratories Market Cap
Abbott Laboratories has a market cap or net worth of €186.16 billion as of December 22, 2025. Its market cap has decreased by -2.54% in one year.
Market Cap
186.16B
Enterprise Value
190.90B
Revenue
37.37B
Ranking
n/a
PE Ratio
15.68
Stock Price
€107.18
Market Cap Chart
Since January 2, 1968, Abbott Laboratories's market cap has increased from 636.28M to 186.16B, an increase of 29,157.17%. That is a compound annual growth rate of 10.29%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 19, 2025 | 186.16B | -1.76% |
| Dec 31, 2024 | 189.49B | 9.61% |
| Dec 29, 2023 | 172.88B | -3.48% |
| Dec 30, 2022 | 179.12B | -15.60% |
| Dec 31, 2021 | 212.23B | 38.39% |
| Dec 31, 2020 | 153.36B | 12.04% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Merck KGaA | 51.87B |
| Siemens Healthineers AG | 49.61B |
| Bayer Aktiengesellschaft | 35.25B |
| Fresenius SE & Co. KGaA | 27.20B |
| Sartorius Aktiengesellschaft | 14.73B |
| Fresenius Medical Care AG | 11.50B |
| Fielmann Group AG | 3.62B |
| Carl Zeiss Meditec AG | 3.51B |